Green synthesis of silver and titanium dioxide nanoparticles using Euphorbia prostrata extract shows shift from apoptosis to G0/G1 arrest followed by necrotic cell death in Leishmania donovani

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 8, 2015, Pages 4782-4799

  Zahir, Abdul Abduz ^a   Chauhan, Indira Singh ^b   Bagavan, Asokan ^a   Kamaraj, Chinnaperumal ^a   Elango, Gandhi ^a   Shankar, Jai ^d   Arjaria, Nidhi ^d   Roopan, Selvaraj Mohana ^c   Rahuman, Abdul Abdul ^a   Singh, Neeloo ^b  

^a C ABDUL HAKEEM COLLEGE   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c VIT UNIVERSITY   (India)

^d CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; EUPHORBIA PROSTRATA EXTRACT; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; ANTIPROTOZOAL AGENT; CASPASE; METAL NANOPARTICLE; PLANT EXTRACT; SILVER; TITANIUM; TITANIUM DIOXIDE;

AMASTIGOTE; ANIMAL CELL; ANTILEISHMANIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DEATH; CELL POPULATION; CELL VIABILITY; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DNA FRAGMENTATION ASSAY; DRUG SYNTHESIS; EUPHORBIA; EUPHORBIA PROSTRATA; G1 PHASE CELL CYCLE CHECKPOINT; GIEMSA STAIN; GRAIN; GREEN CHEMISTRY; IC50; IN VITRO STUDY; INHIBITORY CONCENTRATION; LEISHMANIA DONOVANI; MACROPHAGE CULTURE; MOUSE; NONHUMAN; PARTICLE SIZE; PLANT LEAF; PRIORITY JOURNAL; PROMASTIGOTE; TRANSMISSION ELECTRON MICROSCOPY; TUNEL ASSAY; X RAY DIFFRACTION; CELL CYCLE CHECKPOINT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CHEMISTRY; DRUG EFFECTS; LEISHMANIASIS, VISCERAL; METABOLISM; NECROSIS;

ANTIPROTOZOAL AGENTS; APOPTOSIS; CASPASES; CELL CYCLE CHECKPOINTS; EUPHORBIA; G1 PHASE; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; METAL NANOPARTICLES; NECROSIS; PLANT EXTRACTS; PLANT LEAVES; RESTING PHASE, CELL CYCLE; SILVER; TITANIUM;

EID: 84939817799     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00098-15     Document Type: Article

References (56)

1. Desjeux P. 2004. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305-318. http://dx.doi.org/10.1016/j.cimid.2004.03.004.
2. Richard JV, Werbovetz KA. 2010. New antileishmanial candidates and lead compounds. Curr Opin Chem Biol 14:447-455. http://dx.doi.org/10.1016/j.cbpa.2010.03.023.
3. Ezra N, Ochoa MT, Craft N. 2010. Human immunodeficiency virus and leishmaniasis. J Global Infect Dis 2:248. http://dx.doi.org/10.4103/0974-777X.68528.
4. Kim BY, Rutka JT, Chan WC. 2010. Nanomedicine. N Engl J Med 363:2434-2443. http://dx.doi.org/10.1056/NEJMra0912273.
5. Irache JM, Esparza I, Gamazo C, Agüeros M, Espuelas S. 2011. Nanomedicine: novel approaches in human and veterinary therapeutics. Vet Parasitol 180:47-71. http://dx.doi.org/10.1016/j.vetpar.2011.05.028.
6. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ. 2005. The bactericidal effect of silver nanoparticles. Nanotechnology 16:2346. http://dx.doi.org/10.1088/0957-4484/16/10/059.
7. Sinha S, Pan I, Chanda P, Sen SK. 2009. Nanoparticles fabrication using ambient biological resources. J Appl Biosci 19:1113-1130.
8. Bhainsa KC, D'souza S. 2006. Extracellular biosynthesis of silver nanoparticles using the fungus Aspergillus fumigatus. Colloids Surf B Biointerfaces 47:160-164. http://dx.doi.org/10.1016/j.colsurfb.2005.11.026.
9. Mohebali M, Rezayat M, Gilani K, Sarkar S, Akhoundi B, Esmaeili J, Satvat T, Elikaee S, Charehdar S, Hooshyar H. 2009. Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study. DARU J Pharm Sci 17:285-289.
10. Zampa MF, Araujo I, Costa V, Nery Costa CH, Santos JR, Jr, Zucolotto V, Eiras C, Leite JRS. 2009. Leishmanicidal activity and immobilization of dermaseptin 01 antimicrobial peptides in ultrathin films for nanomedicine applications. Nanomedicine 5:352-358. http://dx.doi.org/10.1016/j.nano.2008.11.001.
11. Allahverdiyev AM, Abamor ES, Bagirova M, Ustundag CB, Kaya C, Kaya F, Rafailovich M. 2011. Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light. Int J Nanomed 6:2705.
12. Torabi N, Mohebali M, Shahverdi AR, Rezayat SM, Edrissian GH, Esmaeili J, Charehdar S. 2011. Nanogold for the treatment of zoonotic cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an animal trial with methanol extract of Eucalyptus camaldulensis. J Pharm Health Sci 1:13-16.
13. Navarro L, Dunoyer P, Jay F, Arnold B, Dharmasiri N, Estelle M, Voinnet O, Jones JD. 2006. A plant miRNA contributes to antibacterial resistance by repressing auxin signaling. Science 312:436-439. http://dx.doi.org/10.1126/science.1126088.
14. Wiesenthal A, Hunter L, Wang S, Wickliffe J, Wilkerson M. 2011. Nanoparticles: small and mighty. Int J Dermatol 50:247-254. http://dx.doi.org/10.1111/j.1365-4632.2010.04815.x.
15. Das S, Roy P, Mondal S, Bera T, Mukherjee A. 2013. One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis. Colloids Surf B Biointerfaces 107:27-34. http://dx.doi.org/10.1016/j.colsurfb.2013.01.061.
16. Sundrarajan M, Gowri S. 2011. Green synthesis of titanium dioxide nanoparticles by Nyctanthes arbor-tristis leaf extract. Chalcogenide Lett 8:447-451.
17. Schmelzer GH, Gurib-Fakim A. 2008. Medicinal plants 1. PROTA Foundation. Backhuys Publishers, Wageningen, Netherlands.
18. Rene K, Hortense GK, Pascal W, Jean Alexis M, Vidal PE, Michel Archange F, Christine FM. 2007. Activity of aqueous ethanol extract of Euphorbia prostrata ait on Shigella dysenteriae type 1-induced diarrhea in rats. Indian J Pharmacol 39:240. http://dx.doi.org/10.4103/0253-7613.37275.
19. Kerboeuf D, Riou M, Guégnard F. 2008. Flavonoids and related compounds in parasitic disease control. Mini Rev Med Chem 8:116-128. http://dx.doi.org/10.2174/138955708783498168.
20. Radtke OA, Foo LY, Lu Y, Kiderlen AF, Kolodziej H. 2003. Evaluation of sage phenolics for their antileishmanial activity and modulatory effects on interleukin-6, interferon and tumour necrosis factor-alpha-release in RAW 264.7 cells. Zeitschrift Naturforsch C 58:395-400.
21. Sharma U, Singh D, Kumar P, Dobhal M, Singh S. 2011. Antiparasitic activity of plumericin & isoplumericin isolated from Plumeria bicolor against Leishmania donovani. Indian J Med Res 134:709. http://dx.doi.org/10.4103/0971-5916.91005.
22. Parashar V, Parashar R, Sharma B, Pandey AC. 2009. Parthenium leaf extract mediated synthesis of silver nanoparticles: a novel approach towards weed utilization. Digest J Nanomaterials Biostructures 4:45-50.
23. Veerasamy R, Xin TZ, Gunasagaran S, Xiang TFW, Yang EFC, Jeyakumar N, Dhanaraj SA. 2011. Biosynthesis of silver nanoparticles using mangosteen leaf extract and evaluation of their antimicrobial activities. J Saudi Chemical Soc 15:113-120. http://dx.doi.org/10.1016/j.jscs.2010.06.004.
24. Horcas I, Fernandez R, Gomez-Rodriguez J, Colchero J, Gómez-Herrero J, Baro A. 2007. WSXM: a software for scanning probe microscopy and a tool for nanotechnology. Rev Sci Instruments 78:013705. http://dx.doi.org/10.1063/1.2432410.
25. Ausloos P, Clifton C, Lias S, Mikaya A, Stein S, Tchekhovskoi D, Sparkman O, Zaikin V, Zhu D. 1999. The critical evaluation of a comprehensive mass spectral library. J Am Soc Mass Spectrom 10:287-299. http://dx.doi.org/10.1016/S1044-0305(98)00159-7.
26. Kaur J, Kumar P, Tyagi S, Pathak R, Batra S, Singh P, Singh N. 2011. In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis. Antimicrob Agents Chemother 55:659-666. http://dx.doi.org/10.1128/AAC.00436-10.
27. Kaur J, Sundar S, Singh N. 2010. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani. J Antimicrob Chemother 65:1742-1748. http://dx.doi.org/10.1093/jac/dkq189.
28. Ghosh S, Debnath S, Hazra S, Hartung A, Thomale K, Schultheis M, Kapkova P, Schurigt U, Moll H, Holzgrabe U. 2011. Valeriana wallichii root extracts and fractions with activity against Leishmania spp. Parasitol Res 108:861-871. http://dx.doi.org/10.1007/s00436-010-2127-0.
29. Wong IL, Chan K-F, Chen Y-F, Lun Z-R, Chan TH, Chow LM. 2014. In vitro and in vivo efficacy of novel flavonoid dimers against cutaneous leishmaniasis. Antimicrob Agents Chemother 58:3379-3388. http://dx.doi.org/10.1128/AAC.02425-13.
30. Chouhan G, Islamuddin M, Ahmad F, Sahal D, Afrin F. 2014. Antileishmanial Potential of Piper nigrum Seed Extracts against Leishmania donovani. Open J Med Microbiol 4:228. http://dx.doi.org/10.4236/ojmm.2014.44025.
31. Rosa MDSS, Mendonça-Filho RR, Bizzo HR, de Almeida Rodrigues I, Soares RMA, Souto-Padrón T, Alviano CS, Lopes AHC. 2003. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob Agents Chemother 47:1895-1901. http://dx.doi.org/10.1128/AAC.47.6.1895-1901.2003.
32. Gould MK, Vu XL, Seebeck T, de Koning HP. 2008. Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assay. Anal Biochem 382:87-93. http://dx.doi.org/10.1016/j.ab.2008.07.036.
33. Gaur U, Showalter M, Hickerson S, Dalvi R, Turco SJ, Wilson ME, Beverley SM. 2009. Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts. Exp Parasitol 122:182-191. http://dx.doi.org/10.1016/j.exppara.2009.03.014.
34. Kaur J, Singh BK, Tripathi RP, Singh P, Singh N. 2009. Leishmania donovani: a glycosyl dihydropyridine analogue induces apoptosis like cell death via targeting pteridine reductase 1 in promastigotes. Exp Parasitol 123:258-264. http://dx.doi.org/10.1016/j.exppara.2009.07.009.
35. Marinho FA, Gonçalves KC, Oliveira SS, Gonçalves DS, Matteoli FP, Seabra SH, Oliveira ACS, Bellio M, Oliveira SS, Souto-Padrón T. 2014. The calpain inhibitor MDL28170 induces the expression of apoptotic markers in Leishmania amazonensis promastigotes. PLoS One 9:e87659. http://dx.doi.org/10.1371/journal.pone.0087659.
36. Mukherjee SB, Das M, Sudhandiran G, Shaha C. 2002. Increase in cytosolic Ca2+ levels through the activation of non-selective cation channels induced by oxidative stress causes mitochondrial depolarization leading to apoptosis-like death in Leishmania donovani promastigotes. J Biol Chem 277:24717-24727. http://dx.doi.org/10.1074/jbc.M201961200.
37. Sarkar A, Mandal G, Singh N, Sundar S, Chatterjee M. 2009. Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate. Exp Parasitol 122:299-305. http://dx.doi.org/10.1016/j.exppara.2009.04.012.
38. Dubey M, Bhadauria S, Kushwah B. 2009. Green synthesis of nanosilver particles from extract of Eucalyptus hybrida (safeda) leaf. Dig J Nanomater Biostruct 4:537-543.
39. Liu Z, Hong L, Guo B. 2005. Physicochemical and electrochemical characterization of anatase titanium dioxide nanoparticles. J Power Sources 143:231-235. http://dx.doi.org/10.1016/j.jpowsour.2004.11.056.
40. Coates J. 2000. Interpretation of infrared spectra, a practical approach, p 10815-10837. In R. A. Meyers (ed), Encyclopedia of analytical chemistry. John Wiley & Sons, Ltd., Chichester, United Kingdom.
41. Logeswari P, Silambarasan S, Abraham J. 2012. Synthesis of silver nanoparticles using plants extract and analysis of their antimicrobial property. J Saudi Chem Soc 19:311-317.
42. Kaur J, Dutta S, Chang K-P, Singh N. 2013. A member of the Ras oncogene family, RAP1A, mediates antileishmanial activity of monastrol. J Antimicrob Chemother 68:1071-1080. http://dx.doi.org/10.1093/jac/dks507.
43. Efuet ET, Keyomarsi K. 2006. Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome. Cancer Res 66: 1040-1051. http://dx.doi.org/10.1158/0008-5472.CAN-05-3416.
44. Martynoga B, Morrison H, Price DJ, Mason JO. 2005. Foxg1 is required for specification of ventral telencephalon and region-specific regulation of dorsal telencephalic precursor proliferation and apoptosis. Dev Biol 283:113-127. http://dx.doi.org/10.1016/j.ydbio.2005.04.005.
45. Chipuk JE, Green DR. 2005. Do inducers of apoptosis trigger caspase-independent cell death? Nature Rev Mol Cell Biol 6:268-275. http://dx.doi.org/10.1038/nrm1573.
46. Raveendran P, Fu J, Wallen SL. 2006. A simple and "green" method for the synthesis of Au, Ag, and Au-Ag alloy nanoparticles. Green Chem 8:34-38. http://dx.doi.org/10.1039/B512540E.
47. Duarte N, Kayser O, Abreu P, Ferreira MJU. 2008. Antileishmanial activity of piceatannol isolated from Euphorbia lagascae seeds. Phytotherapy Res 22:455-457. http://dx.doi.org/10.1002/ptr.2334.
48. McNeil SE. 2011. Characterization of nanoparticles intended for drug delivery. Springer, New York, NY.
49. Weingärtner A, Kemmer G, Müller FD, Zampieri RA, dos Santos MG, Schiller J, Pomorski TG. 2012. Leishmania promastigotes lack phosphatidylserine but bind annexin V upon permeabilization or miltefosine treatment. PLoS One 7:e42070. http://dx.doi.org/10.1371/journal.pone.0042070.
50. Chowdhury S, Mukherjee T, Chowdhury SR, Sengupta S, Mukhopadhyay S, Jaisankar P, Majumder HK. 2014. Disuccinyl betulin triggers metacaspase-dependent endonuclease G-mediated cell death in unicellular protozoan parasite Leishmania donovani. Antimicrob Agents Chemother 58:2186-2201. http://dx.doi.org/10.1128/AAC.02193-13.
51. Bicknell GR, Cohen GM. 1995. Cleavage of DNA to large kilobase pair fragments occurs in some forms of necrosis as well as apoptosis. Biochem Biophys Res Commun 207:40-47. http://dx.doi.org/10.1006/bbrc.1995.1150.
52. Wheeler RJ, Gluenz E, Gull K. 2011. The cell cycle of Leishmania: morphogenetic events and their implications for parasite biology. Mol Microbiol 79:647-662. http://dx.doi.org/10.1111/j.1365-2958.2010.07479.x.
53. Ganapathi AP, Devaki R, Thuniki NR, Manna J, Tirumuru B, Gopu CR, Deepthi SB, Trivedi R, Rana RK, Hasan A. 2014. In vitro assessment of Ag and TiO2 nanoparticles cytotoxicity. Int J Res Med Sci 2:1360-1367. http://dx.doi.org/10.5455/2320-6012.ijrms20141122.
54. Chen C-H, Chen C-H, Shaw C-Y, Chen C-C, Tsai Y-C. 2002. 2,3,4-Trimethyl-5,7-dihydroxy-2,3-dihydrobenzofuran, a novel antioxidant, from Penicillium citrinum F5. J Nat Prod 65:740-741. http://dx.doi.org/10.1021/np010605o.
55. Baiocco P, Ilari A, Ceci P, Orsini S, Gramiccia M, Di Muccio T, Colotti G. 2011. Inhibitory effect of silver nanoparticles on trypanothione reductase activity and Leishmania infantum proliferation. ACS Med Chem Lett 2:230-233. http://dx.doi.org/10.1021/ml1002629.
56. Van Miert S, Dyck SV, Schmidt TJ, Brun R, Vlietinck A, Lemière G, Pieters L. 2005. Antileishmanial activity, cytotoxicity and QSAR analysis of synthetic dihydrobenzofuran lignans and related benzofurans. Bioorg Med Chem 13:661-669. http://dx.doi.org/10.1016/j.bmc.2004.10.058.